Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.

OBJECTIVE--To assess whether monthly treatment with intravenous methylprednisolone enhances or accelerates the effect of disease modifying drugs in patients with rheumatoid arthritis. DESIGN--A 12 month double blind, placebo controlled, multicentre trial in which patients with active rheumatoid arth...

詳細記述

保存先:
書誌詳細
主要な著者: Hansen, T M, Kryger, P, Elling, H, Haar, D, Kreutzfeldt, M, Ingeman-Nielsen, M W, Olsson, A T, Pedersen, C, Rahbek, A, Tvede, N
フォーマット: Artigo
言語:Inglês
出版事項: 1990
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1663457/
https://ncbi.nlm.nih.gov/pubmed/2202458
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料